e-learning
resources
Virtual 2021
05.09.2021
Symptoms across respiratory diseases and impact of COVID-19
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Coronaphobia and physical activity level in patients with non-cystic fibrosis bronchiectasis during COVID-19 pandemic
M. Firat (Ankara, Turkey), N. Vardar-Yagli (Ankara, Turkey), A. Cakmak (Ankara, Turkey), M. Saglam (Ankara, Turkey), E. Calik-Kutukcu (Ankara, Turkey), D. Inal-Ince (Ankara, Turkey), L. Coplu (Ankara, Turkey)
Source:
Virtual Congress 2021 – Symptoms across respiratory diseases and impact of COVID-19
Session:
Symptoms across respiratory diseases and impact of COVID-19
Session type:
E-poster
Number:
346
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Firat (Ankara, Turkey), N. Vardar-Yagli (Ankara, Turkey), A. Cakmak (Ankara, Turkey), M. Saglam (Ankara, Turkey), E. Calik-Kutukcu (Ankara, Turkey), D. Inal-Ince (Ankara, Turkey), L. Coplu (Ankara, Turkey). Coronaphobia and physical activity level in patients with non-cystic fibrosis bronchiectasis during COVID-19 pandemic. 346
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Physical activity evaluation in non-cystic fibrosis bronchiectasis patients
Source: International Congress 2017 – Assessing pulmonary and extra-pulmonary function in chronic disease
Year: 2017
HRCT features in patients with severe asthma and non-cystic fibrosis bronchiectasis.
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020
Non-cystic fibrosis bronchiectasis in children
Source: Virtual Congress 2021 – Posters in paediatric bronchology
Year: 2021
Exercise capacity in patients with cystic fibrosis vs non-cystic fibrosis bronchiectasis
Source: International Congress 2018 – Mechanisms that underlie exercise limitation in various respiratory diseases
Year: 2018
Prevalence of non-cystic fibrosis bronchiectasis in patients with severe asthma: a real-life study
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020
Comparison of exercise capacity, physical activity level and quality of life in patients with different severity of non-cystic fibrosis bronchiectasis>
Source: Virtual Congress 2021 – Peripheral muscle function, exercise capacity and functional status in respiratory disease
Year: 2021
The prevalence of non-cystic fibrosis bronchiectasis in a pediatric respiratory unit
Source: International Congress 2018 – Orphan diseases in children
Year: 2018
Factors associated with recurrence of severe exacerbations in Non-cystic fibrosis bronchiectasis in developping countries.
Source: International Congress 2019 – Clinical problems
Year: 2019
The relationship of walking speed with clinical parameters in patients with non-cystic fibrosis bronchiectasis
Source: Virtual Congress 2020 – Tapas of respiratory physiotherapy
Year: 2020
Inflammatuary markers in induced sputum and clinical parameters in children with non-cystic fibrosis bronchiectasis
Source: Annual Congress 2004 - Chronic respiratory illness in childhood
Year: 2004
Assessing response to treatment of exacerbations of bronchiectasis in adults
Source: Eur Respir J 2009; 33: 312-318
Year: 2009
Non-cystic fibrosis bronchiectasis: series of 89 patients
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008
Role of non-cystic fibrosis bronchiectasis in hospitalized patients with acute exacerbation of COPD
Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies?
Year: 2017
Exposure-response relationships of brensocatib in patients with non-cystic fibrosis bronchiectasis (NCFBE)
Source: Virtual Congress 2021 – ALERT: bronchiectasis and COVID
Year: 2021
Non-cystic fibrosis bronchiectasis
Source: Eur Respir Monogr 2017; 77: 181-198
Year: 2017
Non-cystic fibrosis bronchiectasis
Source: International Congress 2019 – Recent clinical advances in inhalation therapy
Year: 2019
Immuno-allertypes in non-cystic fibrosis bronchiectasis
Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Year: 2018
Non-cystic fibrosis bronchiectasis
Source: Eur Respir Monogr 2017; 77: 38-57
Year: 2017
Non-cystic fibrosis bronchiectasis
Source: Virtual Congress 2020 – Paediatric year in review
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept